Should cefepime be used for any bloodstream infections caused by ceftriaxone-resistant, cefepime-susceptible Enterobacterales?

Int J Antimicrob Agents. 2023 Sep;62(3):106912. doi: 10.1016/j.ijantimicag.2023.106912. Epub 2023 Jul 5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Cefepime / pharmacology
  • Ceftriaxone* / pharmacology
  • Ceftriaxone* / therapeutic use
  • Cephalosporins / pharmacology
  • Cephalosporins / therapeutic use
  • Humans
  • Microbial Sensitivity Tests
  • Sepsis* / drug therapy
  • beta-Lactamases

Substances

  • Cefepime
  • Ceftriaxone
  • Anti-Bacterial Agents
  • Cephalosporins
  • beta-Lactamases